SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 144.92 |
| Enterprise Value ($M) | 142.75 |
| Book Value ($M) | 92.12 |
| Book Value / Share | 1.86 |
| Price / Book | 1.57 |
| NCAV ($M) | 26.45 |
| NCAV / Share | 0.53 |
| Price / NCAV | 5.48 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.23 |
| Return on Assets (ROA) | 0.18 |
| Return on Equity (ROE) | 0.75 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.45 |
| Current Ratio | 1.54 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 147.66 |
| Assets | 213.33 |
| Liabilities | 121.21 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 230.50 |
| Operating Income | 31.00 |
| Net Income | 30.30 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 38.90 |
| Cash from Investing | -20.40 |
| Cash from Financing | -33.90 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 5.60 | -27.38 | |
| 13G/A | Camber Capital Management LP | 0.00 | ||
| 13G/A | Frazier Life Sciences Public Fund, L.P. | 0.00 | -100.00 | |
| 13G/A | Acorn Bioventures, L.p. | 8.00 | ||
| 13G/A | Millennium Management Llc | 3.90 | -40.14 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 118,527 | 426,982 | 27.76 | |
| 98,084 | 342,674 | 28.62 | |
| 149,221 | 369,705 | 40.36 | |
| 101,230 | 266,631 | 37.97 | |
| 53,307 | 177,551 | 30.02 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| OPTN – OptiNose, Inc. | ORIC – ORIC Pharmaceuticals, Inc. |
| OVID – Ovid Therapeutics Inc. | PCRX – Pacira BioSciences, Inc. |
| PCVX – Vaxcyte, Inc. |